2023-01-012023-12-312023-12-31false04770324DERWENT HEALTHCARE LIMITED2024-08-0186900iso4217:GBPxbrli:pure047703242023-01-01047703242023-12-31047703242023-01-012023-12-31047703242022-01-01047703242022-12-31047703242022-01-012022-12-3104770324bus:SmallEntities2023-01-012023-12-3104770324bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3104770324bus:FullAccounts2023-01-012023-12-3104770324bus:PrivateLimitedCompanyLtd2023-01-012023-12-3104770324core:WithinOneYear2023-12-3104770324core:AfterOneYear2023-12-3104770324core:WithinOneYear2022-12-3104770324core:AfterOneYear2022-12-3104770324core:ShareCapital2023-12-3104770324core:SharePremium2023-12-3104770324core:RevaluationReserve2023-12-3104770324core:OtherReservesSubtotal2023-12-3104770324core:RetainedEarningsAccumulatedLosses2023-12-3104770324core:ShareCapital2022-12-3104770324core:SharePremium2022-12-3104770324core:RevaluationReserve2022-12-3104770324core:OtherReservesSubtotal2022-12-3104770324core:RetainedEarningsAccumulatedLosses2022-12-3104770324core:LandBuildings2023-12-3104770324core:PlantMachinery2023-12-3104770324core:Vehicles2023-12-3104770324core:FurnitureFittings2023-12-3104770324core:OfficeEquipment2023-12-3104770324core:NetGoodwill2023-12-3104770324core:IntangibleAssetsOtherThanGoodwill2023-12-3104770324core:ListedExchangeTraded2023-12-3104770324core:UnlistedNon-exchangeTraded2023-12-3104770324core:LandBuildings2022-12-3104770324core:PlantMachinery2022-12-3104770324core:Vehicles2022-12-3104770324core:FurnitureFittings2022-12-3104770324core:OfficeEquipment2022-12-3104770324core:NetGoodwill2022-12-3104770324core:IntangibleAssetsOtherThanGoodwill2022-12-3104770324core:ListedExchangeTraded2022-12-3104770324core:UnlistedNon-exchangeTraded2022-12-3104770324core:LandBuildings2023-01-012023-12-3104770324core:PlantMachinery2023-01-012023-12-3104770324core:Vehicles2023-01-012023-12-3104770324core:FurnitureFittings2023-01-012023-12-3104770324core:OfficeEquipment2023-01-012023-12-3104770324core:NetGoodwill2023-01-012023-12-3104770324core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3104770324core:ListedExchangeTraded2023-01-012023-12-3104770324core:UnlistedNon-exchangeTraded2023-01-012023-12-3104770324core:MoreThanFiveYears2023-01-012023-12-3104770324core:Non-currentFinancialInstruments2023-12-3104770324core:Non-currentFinancialInstruments2022-12-3104770324dpl:CostSales2023-01-012023-12-3104770324dpl:DistributionCosts2023-01-012023-12-3104770324core:LandBuildings2023-01-012023-12-3104770324core:PlantMachinery2023-01-012023-12-3104770324core:Vehicles2023-01-012023-12-3104770324core:FurnitureFittings2023-01-012023-12-3104770324core:OfficeEquipment2023-01-012023-12-3104770324dpl:AdministrativeExpenses2023-01-012023-12-3104770324core:NetGoodwill2023-01-012023-12-3104770324core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3104770324dpl:GroupUndertakings2023-01-012023-12-3104770324dpl:ParticipatingInterests2023-01-012023-12-3104770324dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3104770324core:ListedExchangeTraded2023-01-012023-12-3104770324dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3104770324core:UnlistedNon-exchangeTraded2023-01-012023-12-3104770324dpl:CostSales2022-01-012022-12-3104770324dpl:DistributionCosts2022-01-012022-12-3104770324core:LandBuildings2022-01-012022-12-3104770324core:PlantMachinery2022-01-012022-12-3104770324core:Vehicles2022-01-012022-12-3104770324core:FurnitureFittings2022-01-012022-12-3104770324core:OfficeEquipment2022-01-012022-12-3104770324dpl:AdministrativeExpenses2022-01-012022-12-3104770324core:NetGoodwill2022-01-012022-12-3104770324core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3104770324dpl:GroupUndertakings2022-01-012022-12-3104770324dpl:ParticipatingInterests2022-01-012022-12-3104770324dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3104770324core:ListedExchangeTraded2022-01-012022-12-3104770324dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3104770324core:UnlistedNon-exchangeTraded2022-01-012022-12-3104770324core:NetGoodwill2023-12-3104770324core:IntangibleAssetsOtherThanGoodwill2023-12-3104770324core:LandBuildings2023-12-3104770324core:PlantMachinery2023-12-3104770324core:Vehicles2023-12-3104770324core:FurnitureFittings2023-12-3104770324core:OfficeEquipment2023-12-3104770324core:AfterOneYear2023-12-3104770324core:WithinOneYear2023-12-3104770324core:ListedExchangeTraded2023-12-3104770324core:UnlistedNon-exchangeTraded2023-12-3104770324core:ShareCapital2023-12-3104770324core:SharePremium2023-12-3104770324core:RevaluationReserve2023-12-3104770324core:OtherReservesSubtotal2023-12-3104770324core:RetainedEarningsAccumulatedLosses2023-12-3104770324core:NetGoodwill2022-12-3104770324core:IntangibleAssetsOtherThanGoodwill2022-12-3104770324core:LandBuildings2022-12-3104770324core:PlantMachinery2022-12-3104770324core:Vehicles2022-12-3104770324core:FurnitureFittings2022-12-3104770324core:OfficeEquipment2022-12-3104770324core:AfterOneYear2022-12-3104770324core:WithinOneYear2022-12-3104770324core:ListedExchangeTraded2022-12-3104770324core:UnlistedNon-exchangeTraded2022-12-3104770324core:ShareCapital2022-12-3104770324core:SharePremium2022-12-3104770324core:RevaluationReserve2022-12-3104770324core:OtherReservesSubtotal2022-12-3104770324core:RetainedEarningsAccumulatedLosses2022-12-3104770324core:NetGoodwill2022-01-0104770324core:IntangibleAssetsOtherThanGoodwill2022-01-0104770324core:LandBuildings2022-01-0104770324core:PlantMachinery2022-01-0104770324core:Vehicles2022-01-0104770324core:FurnitureFittings2022-01-0104770324core:OfficeEquipment2022-01-0104770324core:AfterOneYear2022-01-0104770324core:WithinOneYear2022-01-0104770324core:ListedExchangeTraded2022-01-0104770324core:UnlistedNon-exchangeTraded2022-01-0104770324core:ShareCapital2022-01-0104770324core:SharePremium2022-01-0104770324core:RevaluationReserve2022-01-0104770324core:OtherReservesSubtotal2022-01-0104770324core:RetainedEarningsAccumulatedLosses2022-01-0104770324core:AfterOneYear2023-01-012023-12-3104770324core:WithinOneYear2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3104770324core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3104770324core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3104770324core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3104770324core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3104770324core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3104770324bus:Director12023-01-012023-12-3104770324bus:Director22023-01-012023-12-3104770324core:FurnitureFittingsToolsEquipment2022-12-3104770324core:FurnitureFittingsToolsEquipment2023-01-012023-12-3104770324core:FurnitureFittingsToolsEquipment2023-12-31047703241bus:Director22023-01-01047703241bus:Director22023-01-012023-12-31047703241bus:Director22023-12-31047703242023-01-01047703242023-01-012023-12-31047703242023-12-31

DERWENT HEALTHCARE LIMITED

Registered Number
04770324
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

DERWENT HEALTHCARE LIMITED
Company Information
for the year from 1 January 2023 to 31 December 2023

Directors

MIDDLETON, Glynis Mara
MIDDLETON, Philip John

Company Secretary

MIDDLETON, Glynis Mara

Registered Address

Widdrington House
35 South Side
Stamfordham Newcastle Upon Tyne
NE18 0PD

Registered Number

04770324 (England and Wales)
DERWENT HEALTHCARE LIMITED
Statement of Financial Position
31 December 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets31,063159
1,063159
Current assets
Stocks49,4005,287
Debtors5138,89562,424
Cash at bank and on hand5,5905,344
153,88573,055
Creditors amounts falling due within one year6(154,702)(31,073)
Net current assets (liabilities)(817)41,982
Total assets less current liabilities24642,141
Provisions for liabilities7(202)(30)
Net assets4442,111
Capital and reserves
Called up share capital100100
Profit and loss account(56)42,011
Shareholders' funds4442,111
The financial statements were approved and authorised for issue by the Board of Directors on 1 August 2024, and are signed on its behalf by:
MIDDLETON, Glynis Mara
Director
Registered Company No. 04770324
DERWENT HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings25-
Office Equipment-33
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Government grants or assistance
Government grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which they become receivable.
2.Average number of employees

20232022
Average number of employees during the year22
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 January 233,1422,4845,626
Additions-1,4081,408
Disposals-(1,234)(1,234)
At 31 December 233,1422,6585,800
Depreciation and impairment
At 01 January 232,9832,4845,467
Charge for year40464504
On disposals-(1,234)(1,234)
At 31 December 233,0231,7144,737
Net book value
At 31 December 231199441,063
At 31 December 22159-159
4.Stocks

2023

2022

££
Finished goods9,4005,287
Total9,4005,287
5.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables105,1476,291
Other debtors32,49554,172
Prepayments and accrued income1,2531,961
Total138,89562,424
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debt. Loans and other financial assets are initially recognised at transaction price including costs and subsequently measured at amortised cost determined using the effective interest method. Included within other debtors is an amount of £9,095 due from the directors (2022: £54,172).
6.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables133,3687,312
Taxation and social security17,42420,090
Other creditors1,4351,316
Accrued liabilities and deferred income2,4752,355
Total154,70231,073
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)20230
Total20230
8.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
MIDDLETON, Philip John54,17277,09498,77132,495
54,17277,09498,77132,495